Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus.

BMC Pharmacol Toxicol · 2020 · PMC7171729 · PMID 32317005

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

reported a significant increase in HDL concentration in patients with 12-week administration of sitagliptin or linagliptin, and showed a decreasing trend in TC, TG, and LD in patients with 12-week administration of sitagliptin, vildagliptin, or linagliptin [ 19 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.